Expansion of Monocytic Myeloid-Derived Suppressor Cells in Patients Under Hemodialysis Might Lead to Cardiovascular and Cerebrovascular Events.

MLA

Xing, Yan-Fang, et al. “Expansion of Monocytic Myeloid-Derived Suppressor Cells in Patients Under Hemodialysis Might Lead to Cardiovascular and Cerebrovascular Events.” Frontiers in Immunology, vol. 11, Jan. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.3389/fimmu.2020.577253.

APA

Xing, Y.-F., Cai, J.-R., Qin, J.-J., Zhou, W.-Y., Li, C.-M., & Li, X. (2021). Expansion of Monocytic Myeloid-Derived Suppressor Cells in Patients Under Hemodialysis Might Lead to Cardiovascular and Cerebrovascular Events. Frontiers in Immunology, 11, N.PAG. https://doi.org/10.3389/fimmu.2020.577253

Chicago

Xing, Yan-Fang, Jia-Rong Cai, Jun-Jian Qin, Wen-Ying Zhou, Can-Ming Li, and Xing Li. 2021. “Expansion of Monocytic Myeloid-Derived Suppressor Cells in Patients Under Hemodialysis Might Lead to Cardiovascular and Cerebrovascular Events.” Frontiers in Immunology 11 (January): N.PAG. doi:10.3389/fimmu.2020.577253.